Subtype of breast cancer influences sentinel lymph node positivity

被引:2
|
作者
Kedzierawski, Piotr [1 ,2 ,6 ]
Bocian, Artur [3 ]
Radowicz-Chil, Agnieszka [2 ,4 ]
Huruk-Kuchinka, Anna [1 ]
Mezyk, Ryszard [5 ]
机构
[1] Holycross Canc Ctr, Dept Radiotherapy, Kielce, Poland
[2] Jan Kochanowski Univ, Fac Med & Hlth Sci, Kielce, Poland
[3] Holycross Canc Ctr, Dept Surg, Kielce, Poland
[4] Holycross Canc Ctr, Dept Pathol, Kielce, Poland
[5] Holycross Canc Ctr, Dept Epidemiol, Kielce, Poland
[6] Holycross Canc Ctr, Dept Radiotherapy, 3 Artwinskiego St, PL-25734 Kielce, Poland
关键词
breast cancer; sentinel lymph node biopsy; biological subtype; CLINICOPATHOLOGICAL CHARACTERISTICS; NEOADJUVANT CHEMOTHERAPY; METASTASIS; RISK; MANAGEMENT; FEATURES;
D O I
10.5114/aoms.2019.88595
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The purpose of the study was to determine the correlation between biological subtype of breast cancer and the risk of its metastasis to a sentinel lymph node.Material and methods: In the analysed group there were 1018 women with breast cancer, clinically node negative, untreated previously. Luminal A subtype was recognised in 57% of patients. A positive sentinel lymph node was detected in 26.5% of women.Results: In the multivariate analysis only age and tumour size proved to be significant for the entire group, respectively: OR = 0.59, p = 0.0004; OR = 1.96; p < 0.0001. For Luminal A subtype values were OR = 0.51, p = 0.0007; OR = 1.78, p = 0.0045, respectively. For Luminal B patients, in women over 61 years, the risk of sentinel node metastasis probability decreases by 67% and for tumours over 21 mm the probability of positive sentinel node metastasis increases by 117%. Conclusions: According to our analysis luminal breast cancers are most numerous subtypes, and in these cases we expect more frequent instances of metastasis to a sentinel node. Following the most updated and modern procedures of breast cancer patients' treatment a procedure of sentinel lymph node biopsy is used, replacing an aggressive treatment in the axilla region. In regards to our analysis we should be more vigilant in estimation of regional lymph nodes in luminal patients under sixty with high grade tumours and the tumour diameter more than 20 mm.
引用
收藏
页码:618 / 625
页数:8
相关论文
共 50 条
  • [31] Sentinel lymph node mapping in breast cancer
    Cody III H.S.
    Breast Cancer, 1999, 6 (1) : 13 - 22
  • [32] Sentinel lymph node biopsy in breast cancer
    Luschin, Gero
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (19-20) : 497 - 500
  • [33] Sentinel lymph node biopsies in breast cancer
    A Hess
    MO Flüβ
    C Nestle-Krämling
    HG Bender
    P Dall
    Breast Cancer Research, 3 (Suppl 1)
  • [34] Sentinel lymph node biopsy in breast cancer
    Rody, A
    Solbach, C
    Kaufmann, M
    CHIRURG, 2004, 75 (08): : 767 - 773
  • [35] LOCATION OF SENTINEL LYMPH NODE IN BREAST CANCER
    Matusz, Petru L.
    Pusztai, Agneta Maria
    Grujic, Daciana
    Mastacaneanu, Mihaela
    Bratu, Tiberiu
    FASEB JOURNAL, 2010, 24
  • [36] Sentinel lymph node biopsy and breast cancer
    Govender, S
    ANZ JOURNAL OF SURGERY, 2004, 74 (04) : 287 - 287
  • [37] Sentinel lymph node biopsy for breast cancer
    Sato, K.
    Shigenaga, R.
    Ueda, S.
    Shigekawa, T.
    Krag, D. N.
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (04) : 322 - 329
  • [38] Sentinel Lymph Node Pressure in Breast Cancer
    Nathanson, S. David
    Mahan, Meredith
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (13) : 3791 - 3796
  • [39] Status of Sentinel Lymph Node for Breast Cancer
    Moncayo, Valeria M.
    Aarsvold, John N.
    Grant, Sandra F.
    Bartley, Scott C.
    Alazraki, Naomi P.
    SEMINARS IN NUCLEAR MEDICINE, 2013, 43 (04) : 281 - 293
  • [40] Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: The possibility to omit sentinel lymph node biopsy
    Nakauchi, Chiaki
    Naoi, Yasuto
    Shimazu, Kenzo
    Tsunashima, Ryo
    Nishio, Minako
    Maruyama, Naomi
    Shimomura, Atsushi
    Kagara, Naofumi
    Shimoda, Masashi
    Kim, Seung Jin
    Noguchi, Shinzaburo
    CANCER LETTERS, 2014, 353 (01) : 52 - 58